The Furlong hydroxyapatite-coated femoral prosthesis. A 4- to 7-year follow-up study.
We report the clinical and radiograph outcome of 77 Furlong hydroxyapatite fully coated femoral prosthesis in 71 patients undergoing primary total hip replacement, with mean follow-up of 65 months (range 48-82 months). The patients' average age at surgery was 55 years. The clinical results, as determined by Harris hip score, were excellent or good for 84% of the hips. Thigh pain which was not disturbing was present in 9% of the hips. No femoral component had been revised for aseptic loosening, and none were considered loose radiographically at the time of final follow-up evaluation. Serial radiographs revealed an excellent quality of bone around the prostheses, with positive evidence of bone ingrowth and no signs of impending failure.
Loupasis
G
G
County Hospital, Lincoln, UK.
Hyde
I D
ID
Morris
E W
EW
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019644:Arthroplasty, Replacement, Hip / Q000379:methods*; D001672:Biocompatible Materials; D016009:Chi-Square Distribution; D017886:Durapatite; D005069:Evaluation Studies as Topic; D005260:Female; D005269:Femur; D005500:Follow-Up Studies; D006621:Hip Joint / Q000000981:diagnostic imaging / Q000601:surgery; D006622:Hip Prosthesis / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D011379:Prognosis; D011474:Prosthesis Design; D011475:Prosthesis Failure; D011859:Radiography; D012086:Reoperation; D013499:Surface Properties; D016896:Treatment Outcome
D001672:Biocompatible Materials; D017886:Durapatite